Shandong Sinobioway Biomedicine Co Ltd
Shandong Sinobioway Biomedicine Co., Ltd. engages in the pharmaceutical manufacturing industry in China. The company is involved in the chemical raw materials, chemical product manufacturing, and biopharmaceutical manufacturing; production and sales of medicines. It also offers operating chemical products, such as trimethyl ester and triethyl ester. The company was founded in 2000 and is based in… Read more
Shandong Sinobioway Biomedicine Co Ltd (002581) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.043x
Based on the latest financial reports, Shandong Sinobioway Biomedicine Co Ltd (002581) has a cash flow conversion efficiency ratio of -0.043x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-86.58 Million) by net assets (CN¥1.99 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Shandong Sinobioway Biomedicine Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2024)
This chart illustrates how Shandong Sinobioway Biomedicine Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Shandong Sinobioway Biomedicine Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shandong Sinobioway Biomedicine Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SP Setia Bhd
KLSE:8664
|
0.020x |
|
Qinhuangdao Port Co Ltd
SHG:601326
|
0.048x |
|
Family Zone Cyber Safety Limited
PINK:FMZNF
|
-0.050x |
|
Acrobiosystems Co.Ltd.
SHE:301080
|
N/A |
|
Suzhou Chunqiu Electronic Technology Co Ltd Class A
SHG:603890
|
0.028x |
|
Shaanxi Yanchang Petroleum Chemical Engineering Co Ltd
SHG:600248
|
-0.035x |
|
Trican Well Service Ltd.
PINK:TOLWF
|
0.127x |
|
Stabilus S.A
PINK:SIUAF
|
0.048x |
Annual Cash Flow Conversion Efficiency for Shandong Sinobioway Biomedicine Co Ltd (2007–2024)
The table below shows the annual cash flow conversion efficiency of Shandong Sinobioway Biomedicine Co Ltd from 2007 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥2.02 Billion | CN¥-6.55 Million | -0.003x | +80.72% |
| 2023-12-31 | CN¥2.17 Billion | CN¥-36.51 Million | -0.017x | +23.91% |
| 2022-12-31 | CN¥2.47 Billion | CN¥-54.49 Million | -0.022x | -18.45% |
| 2021-12-31 | CN¥2.47 Billion | CN¥-46.02 Million | -0.019x | -320.54% |
| 2020-12-31 | CN¥2.19 Billion | CN¥18.51 Million | 0.008x | -58.31% |
| 2019-12-31 | CN¥2.39 Billion | CN¥48.41 Million | 0.020x | -23.24% |
| 2018-12-31 | CN¥2.82 Billion | CN¥74.46 Million | 0.026x | -71.58% |
| 2017-12-31 | CN¥2.92 Billion | CN¥271.11 Million | 0.093x | +38.67% |
| 2016-12-31 | CN¥2.53 Billion | CN¥169.32 Million | 0.067x | +4.28% |
| 2015-12-31 | CN¥2.14 Billion | CN¥137.73 Million | 0.064x | -39.90% |
| 2014-12-31 | CN¥749.40 Million | CN¥80.11 Million | 0.107x | -5.07% |
| 2013-12-31 | CN¥738.31 Million | CN¥83.13 Million | 0.113x | +25.83% |
| 2012-12-31 | CN¥704.41 Million | CN¥63.04 Million | 0.089x | -19.17% |
| 2011-12-31 | CN¥672.28 Million | CN¥74.43 Million | 0.111x | -77.09% |
| 2010-12-31 | CN¥177.34 Million | CN¥85.71 Million | 0.483x | +15.97% |
| 2009-12-31 | CN¥129.71 Million | CN¥54.06 Million | 0.417x | +3.22% |
| 2008-12-31 | CN¥116.12 Million | CN¥46.89 Million | 0.404x | +35.21% |
| 2007-12-31 | CN¥83.94 Million | CN¥25.07 Million | 0.299x | -- |